Paddock et al v. Novartis Pharmaceuticals Corporation
| Delaware District Court | |
| Judge: | Jennifer L Hall |
| Referred: | Sherry R Fallon |
| Case #: | 1:25-cv-00407 |
| Nature of Suit | 365 Torts - Personal Injury - Product Liability |
| Cause | 28:1332 Diversity-Notice of Removal |
| Case Filed: | Apr 01, 2025 |
| Last checked: Thursday Apr 03, 2025 1:07 AM EDT |
|
Defendant
Novartis Pharmaceuticals Corporation
|
Represented By
|
|
Plaintiff
Taryn Anthony
|
Represented By
|
|
Plaintiff
Sandra Blanchette
|
Represented By
|
|
Plaintiff
Laurie Boyle
|
Represented By
|
|
Plaintiff
Michelle Del Valle
|
Represented By
|
|
Plaintiff
Tove Ghent
|
Represented By
|
|
Plaintiff
Holly McCullogh
|
Represented By
|
|
Plaintiff
Cheyenne Moses
|
Represented By
|
|
Plaintiff
Keri Sue Paddock
|
Represented By
|
|
Plaintiff
Christina Polanowski
|
Represented By
|
|
Plaintiff
Julia Roer
|
Represented By
|
| Docket last updated: 04/17/2025 11:59 PM EDT |
| Monday, April 14, 2025 | ||
| 6 | 6
order
Oral Order ~Util - Set Hearings
Mon 04/14 12:42 PM
ORAL ORDER SETTING RULE 16(b) CONFERENCE: IT IS HEREBY ORDERED that: (1) A scheduling teleconference pursuant to Fed. R. Civ. P. 16(b) will be held on May 14, 2025 at 3:00 P.M. (2) The parties are required to prepare for the teleconference by conferring on all matters under Rule 16 and D. Del. LR 16 and shall submit a joint proposed scheduling order to the Court no later than May 9, 2025. The Court's form of scheduling order is posted at https://www.ded.uscourts.gov/judge/magistrate-judge-sherry-r-fallon. Portions of the proposed scheduling order falling outside the scope of the referral to the Magistrate Judge (such as pre-trial motions in limine, the pre-trial conference, and trial) shall conform with Judge Hall's form of scheduling order found at https://www.ded.uscourts.gov/judge/district-judge-jennifer-l-hall. The proposed scheduling order shall also include a chart of all relevant deadlines in accordance with Judge Hall's procedures. If the parties have any suggestions or modifications to the standard scheduling order, they may be included in the proposed order for consideration by the Court. (3) If any disputed issue exists regarding the proposed scheduling order, it shall be noted therein, along with the parties' proposed language on the issue for consideration by the Court. Ordered by Judge Sherry R. Fallon on 4/14/2025. (lih) |
|
| 5 | 5
order
Order Referring Case to Magistrate Judge
Mon 04/14 9:46 AM
ORAL ORDER REFERRING CASE to Magistrate Judge Sherry R. Fallon: IT IS HEREBY ORDERED that this case is referred to Magistrate Judge Sherry R. Fallon to hear and resolve all pre-trial matters up to and including summary judgment, subject to 28 U.S.C. § 636(b) and any further order of the Court. All subsequent filings in this action shall be captioned as follows: Civil Action No. 25-407-JLH-SRF. Ordered by Judge Jennifer L. Hall on 4/14/2025. (ceg) |
|
| Wednesday, April 09, 2025 | ||
|
utility
Case Assigned/Reassigned
Wed 04/09 12:50 PM
Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (alb) |
||
| Wednesday, April 02, 2025 | ||
| 4 | 4
answer
Answer to Complaint
Wed 04/02 9:16 AM
ANSWER to Complaint with Jury Demand by Novartis Pharmaceuticals Corporation.(Donelson, Matthew) |
|
| 3 | 3
misc
Disclosure Statement - Rule 7.1
Wed 04/02 9:14 AM
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG, Corporate Parent Novartis Finance Corp for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (Donelson, Matthew) |
|
| Tuesday, April 01, 2025 | ||
| 2 | 2
misc
Magistrate Consent Forms
Wed 04/02 9:02 AM
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (cdd) |
|
| 1 | 1
notice
Notice of Removal
Wed 04/02 8:57 AM
NOTICE OF REMOVAL and copies of documents from Superior Court of the State of Delaware, Case Number K25C-03-046-NEP (Filing fee $405, receipt number ADEDC-4651548)- filed by Novartis Pharmaceuticals Corporation.(cdd) |
|
|
Att: 1
Exhibit A,
|
||
|
Att: 2
Exhibit B,
|
||
|
Att: 3
Civil Cover Sheet
|
||